<DOC>
	<DOCNO>NCT01615705</DOCNO>
	<brief_summary>The purpose study evaluate whether biomarkers inflammation , genetic thrombophilia coagulation activation influence Post-Thrombotic Syndrome development patient symptomatic proximal deep venous thrombosis .</brief_summary>
	<brief_title>Biomarker Sub Study Compression Stockings Prevent Post-Thrombotic Syndrome ( SOX ) Trial</brief_title>
	<detailed_description>The post-thrombotic syndrome ( PTS ) frequent , burdensome costly condition occur one third patient episode deep vein thrombosis ( DVT ) . Affected patient chronic leg pain swelling , sometimes develop skin ulcer . Poor understand pathophysiology predictor PTS hamper progress prevention treatment . Biomarkers reflective inflammation , genetic thrombophilia coagulation activation may value predict PTS development patient DVT ; may also provide insight understand underlie mechanisms PTS , could result development test novel therapy prevent treat PTS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<criteria>Consecutive patient first , symptomatic , objectively confirm proximal DVT diagnose within last 14 day ( without concurrent distal DVT pulmonary embolism ) Who contraindications standard treatment heparin and/or warfarin , Who provide inform consent participate Contraindication compression stocking Limited lifespan ( estimate &lt; 6 month ) Geographic inaccessibility prevent return followup visit Inability apply stocking daily unavailability caregiver apply stocking daily Treatment acute DVT thrombolytic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Postphlebitic Syndrome</keyword>
	<keyword>Post-Thrombotic Syndrome</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Markers Inflammation</keyword>
	<keyword>Genetic Thrombophilia</keyword>
	<keyword>Coagulation Activation</keyword>
</DOC>